CTXR
(NASDAQ)
0.7348
-0.0763  (-10.39%)
Volume (24h): 5.30M Day Range: 0.7000 - 0.9800
Market Cap: 26.39M 52W Range: 0.4001 - 1.49
Apr-01-20 12:07PM Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19PR Newswire
Mar-26-20 01:06PM Citius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida AurisPR Newswire
Mar-18-20 01:46PM Citius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor SummitPR Newswire
Mar-16-20 10:22AM Here's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn SituationSimply Wall St.
Mar-03-20 09:45PM Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York CityACCESSWIRE
Feb-26-20 01:00PM Citius Pharmaceuticals to Present at the 2020 LD Micro Virtual ConferencePR Newswire
Feb-25-20 01:00PM Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®PR Newswire
Feb-10-20 01:28PM Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor ConferencePR Newswire
Feb-04-20 01:00PM Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal TrialPR Newswire
Feb-03-20 01:00PM Citius Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsPR Newswire
Jan-27-20 01:00PM Biotech Companies Think Big with Specialization - Fighting Deadly Bacteria and VirusesNewsfile
Dec-19-19 01:00PM Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal TrialPR Newswire
Dec-04-19 01:00PM Citius Pharmaceuticals to Present at the 12th Annual LD Micro Main EventPR Newswire
Nov-08-19 01:00PM Citius Pharmaceuticals Issues Corporate UpdatePR Newswire
Oct-24-19 12:00PM Citius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth ConferencePR Newswire
Oct-15-19 12:00PM MicroCap Rodeo Investor Conference - Lineup for October 15 and 16, 2019ACCESSWIRE
Oct-07-19 12:30PM Citius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal TrialPR Newswire
Oct-03-19 11:00AM Citius Provides Update on Activities From IDWeek 2019PR Newswire
Sep-28-19 11:52AM Insider Buying: The Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Executive Chairman & Secretary Just Bought US$2.0m Worth Of SharesSimply Wall St.
Sep-27-19 03:28PM Citius Announces Closing of $7.0 Million Underwritten Offering Priced At-the-MarketPR Newswire
Sep-25-19 11:00AM Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-MarketPR Newswire
Sep-04-19 10:55AM Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 StudyPR Newswire
Aug-29-19 12:00PM Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.PR Newswire
Jul-30-19 12:00PM Citius Provides Developmental Plans for Mino-WrapPR Newswire
Jul-24-19 07:38PM Have Insiders Been Buying Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Shares?Simply Wall St.
May-24-19 12:53PM Could Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Investor Composition Influence The Stock Price?Simply Wall St.
May-13-19 12:47PM Citius Pharmaceuticals' Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida aurisPR Newswire
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok product, which has completed Phase IIb clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; and Hydro-Lido product, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. It has a collaboration and license agreement with Alpex Pharma S.A. to develop and commercialize orally disintegrating tablet formulations of pharmaceutical products in United States, Canada, and Mexico. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)